Selected article for: "bind ability and domain bind"

Author: Cheng Wang; Shaobo Wang; Daixi Li; Xia Zhao; Songling Han; Tao Wang; Gaomei Zhao; Yin Chen; Fang Chen; Jianqi Zhao; Liting Wang; Wei Sun; Yi Huang; Yongping Su; Dongqing Wei; Jinghong Zhao; Junping Wang
Title: Lectin-like Intestinal Defensin Inhibits 2019-nCoV Spike binding to ACE2
  • Document date: 2020_3_31
  • ID: bzq1xxqb_9
    Snippet: In the present study, we demonstrated that HD5 displayed a strong ability to prevent 2019-nCoV S1 to bind to intestinal epithelial cells by blocking the ligand-binding domain (LBD) of ACE2. Our findings unmasked the innate defense function of intestinal HD5 against 2019-nCoV, which may benefit the on-going development of preventive and therapeutic drugs......
    Document: In the present study, we demonstrated that HD5 displayed a strong ability to prevent 2019-nCoV S1 to bind to intestinal epithelial cells by blocking the ligand-binding domain (LBD) of ACE2. Our findings unmasked the innate defense function of intestinal HD5 against 2019-nCoV, which may benefit the on-going development of preventive and therapeutic drugs.

    Search related documents:
    Co phrase search for related documents
    • defense function and present study: 1, 2, 3
    • epithelial cell and intestinal epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • epithelial cell and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • go development and present study: 1
    • intestinal epithelial cell and present study: 1, 2, 3, 4, 5, 6, 7
    • ligand bind and present study: 1, 2
    • present study and strong ability: 1, 2, 3, 4, 5
    • present study and therapeutic preventive drug: 1